ArticleESMO real world data and digital oncology2026
Impact of the COVID-19 pandemic on cancer incidence, stage, mortality, and short-term survival in Ireland: a population-based analysis.
Article in ESMO real world data and digital oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Concern exists that disruptions to health services in combination with changed health-seeking behaviour as a consequence of the coronavirus disease (COVID-19) pandemic would negatively impact cancer outcomes. The purpose of this study was to assess how the COVID-19 pandemic affected cancer incidence, stage at diagnosis, mortality, and 1-year net survival in Ireland. Materials and methods: Age-standardised incidence and mortality rates were generated for three periods (2018-2019, 2020-2021, and 2022). Quarterly age-standardised incidence rates, incidence rate ratios (IRRs), and percentage change (PC) by cancer site were generated for Q1 2020 to Q4 2021. Annual incidence rates, IRRs and PC by stage at diagnosis were estimated. Age- and stage-adjusted 1-year net survival was estimated using the Pohar-Perme method. Results: The age-standardised quarterly incidence rate of all invasive cancers (excluding nonmelanoma skin cancer) decreased significantly in Q2 2020, by 27% (95% CI -42% to -7%, Conclusions: The COVID-19 pandemic significantly disrupted cancer detection and diagnostic activity in Ireland during 2020. The early overall picture suggests that the resilience and adaptability of the Irish health care system helped to safeguard cancer outcomes during an unprecedented public health crisis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.